Compare Crescent Energy Company Class A Common Stock (CRGY) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crescent Energy Company Class A Common Stock vs Enveric Biosciences Inc — how do they compare? Crescent Energy Company Class A Common Stock trades at $13.01 (market cap $4.30B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.80M). The key difference: Crescent Energy Company Class A Common Stock is far larger — about 632.4× Enveric Biosciences Inc's market cap, and Crescent Energy Company Class A Common Stock pays a 3.69% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crescent Energy Company Class A Common Stock for 0 Days and Enveric Biosciences Inc for 14 Days on average.
| CRGY | ENVB | |
|---|---|---|
Market Cap | $4.30B | $6.80M |
Volume | 15,201,625 | 64,867 |
Sector | Energy | Health |
52-Week High | $15.37 | $10.80 |
52-Week Low | $7.75 | $1.27 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $9.31B | -$1.49M |
Dividend Yield | 3.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ENVB trades at $1.45, down 3.01% on the day, with a bearish technical signal driven by moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten quarterly EPS expectations. Recent positive developments include a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in investor conferences.
The outlook is mixed; analyst consensus is 75% buy with strong earnings beats, but high negative ROE/ROA and operational cash burn pose significant risks. Investment opportunity hinges on successful drug development, while key risks include funding needs and clinical trial outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Crescent Energy Company Class A Common Stock
Crescent Energy acquires, develops, and produces oil and natural gas from onshore U.S. basins. Its portfolio includes producing assets with oil and natural gas exposure.
Read more on CRGY →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
